手机版 客户端

基于PI3K/Akt通路调控DNA甲基化研究参元丹胶囊治疗动脉粥样硬化胰岛素抵抗的分子机制

基于PI3K/Akt通路调控DNA甲基化研究参元丹胶囊治疗动脉粥样硬化胰岛素抵抗的分子机制
  • 导航:首页 > 科学基金
  • 批准号:81673744
  • 批准年度: 2016年
  • 学科分类:中西医结合临床基础(H2902) |
  • 项目负责人:周明学
  • 负责人职称:副研究员
  • 依托单位:首都医科大学
  • 资助金额:60万元
  • 项目类别:面上项目
  • 研究期限:2017年01月01日 至 2020年12月31日
  • 中文关键词: PI3K/Akt;DNA;甲基化;动脉粥样硬化;胰岛素抵抗
  • 英文关键词:atherosclerosis;insulin resistance;DNA methylation;Shenyuan Dan Capsule;PI3K/Akt signaling pathway

项目摘要

中文摘要

大量研究表明,DNA甲基化是动脉粥样硬化(AS)发生的重要机制。甲基化异常可影响胰岛素抵抗(IR)相关基因及通路表达,导致AS发生。前期发现,AS小鼠主动脉IR相关基因启动子区发生高度甲基化,并受PI3K/Akt通路调控。益气逐瘀是中医治疗冠心病的重要治法,既往发现益气逐瘀代表方参元丹胶囊可抑制AS,与提高血清甲基化转移酶和降低胰岛素水平有关,但其是否通过调控PI3K/Akt通路逆转IR基因甲基化发挥抗AS作用尚不清楚。因此提出假说:“益气逐瘀代表方参元丹可调控PI3K/Akt通路,逆转IR相关基因甲基化异常,发挥抗AS作用”。本课题以高脂喂养的ApoE-/-小鼠为观察对象,研究参元丹抗AS过程对IR基因甲基化的影响,并以脂肪细胞为靶细胞,用DNMT抑制剂和通路抑制剂联合干预,研究PI3K/Akt通路在参元丹改善IR基因甲基化异常过程中的作用,为明确参元丹防治AS的作用机制提供实验学依据

英文摘要

A large number of studies have indicated that DNA methylation is one of important mechanisms for the occurrence of atherosclerosis (AS). Aberrant methylation can affect the expression of insulin resistance (IR)-related genes and their regulatory pathways, and further result in the occurrence of AS. Our previous studies showed that the promoter regions of IR related genes (IRS-1 and Pde3B) in AS mouse aorta were highly methylated, and were regulated by PI3K/Akt pathway. Promoting Qi and removing blood stasis is an important treatment on coronary heart diseases in traditional Chinese medicine, Shen-yuan Dan capsule has the inhibitive effects on AS and increased the level of DNA methyl transfer enzyme (DNMT) in atherosclerosis mice serum and decreased the insulin level, but it remains unclear whether Shenyuan-Dan can inverse aberrant methylation of IR-related genes to exert anti-atherosclerotic effects through regulating PI3K/Akt pathway. Therefore, we put forward the hypothesis: "Shen Yuan Dan capsule, one of the typical prescription with the effect of promoting Qi and removing blood stasis, can regulate PI3K/Akt pathway, reverse the DNA methylation status of IR-related genes, and further exert anti-atherosclerotic effects ". Therefore, this study is designed to adopt ApoE-/- mice fed with high-fat diet as AS experimental model to study the effect of Shen Yuan Dan capsule on PI3K/Akt pathway and IR gene methylation status in the process of exerting anti-atherosclerotic effect and adopt adipose cells as target cells, the DNMT inhibitors and inhibitors of the PI3K/Akt pathway were combined used to study the roles of DNA methylation and PI3K/Akt pathway in the process of Shen Yuan Dan improving IR. It provides a new way to study the mechanism oif Shen Yuan Dan capsule preventing AS, one of the typical prescription with the effect of promoting Qi and removing blood stasis.

评估说明

    国家自然科学基金项目“基于PI3K/Akt通路调控DNA甲基化研究参元丹胶囊治疗动脉粥样硬化胰岛素抵抗的分子机制”发布于爱科学iikx,并永久归类于相关科学基金导航中,仅供广大科研工作者查询、学习、选题参考。国科金是根据国家发展科学技术的方针、政策和规划,以及科学技术发展方向,面向全国资助基础研究和应用研究,发挥着促进我国基础研究源头创新的作用。国科金的真正价值在于它能否为科学进步和社会发展带来积极的影响。

此文由 爱科学 编辑!:首页 > 科学基金 > 科学基金3 » 基于PI3K/Akt通路调控DNA甲基化研究参元丹胶囊治疗动脉粥样硬化胰岛素抵抗的分子机制

推荐文章